Invasive Mold Infections in Children: Navigating Troubled Waters with a Broken Compass

Area of Science:

• Pediatric Infectious Diseases
• Mycology
• Hematology/Oncology

Background:

• Increasing incidence of invasive mold infections (IMIs) in pediatric populations, particularly those with hematological malignancies or undergoing stem cell transplants.
• IMIs caused by Aspergillus spp., Mucorales, and other molds present significant morbidity and mortality in children.
• Challenges in diagnosing and treating IMIs in children due to limited pediatric-specific data and treatment guidelines.

Purpose of the Study:

• To review and synthesize current literature on epidemiology, clinical presentations, diagnostics, and management of IMIs in pediatric patients.
• To provide a harmonized overview to aid clinicians in recognizing and managing these infections.
• To highlight the need for improved diagnostic tools and evidence-based treatment strategies in pediatric populations.

Main Methods:

• Comprehensive literature review of invasive mold infections in children.
• Analysis of epidemiological trends, clinical manifestations, and diagnostic advancements.
• Evaluation of current treatment principles, including antifungal agents and pharmacokinetic considerations.

Main Results:

• IMIs are an increasing concern in immunocompromised children, necessitating high clinical suspicion.
• Diagnostic methods are evolving, with progress in immunological and molecular techniques.
• Pediatric IMI treatment is challenging, often relying on extrapolated adult data, with ongoing research into safer antifungal agents.

Conclusions:

• A high index of suspicion is vital for early detection of IMIs in at-risk children.
• Advancements in diagnostics offer improved identification of fungal pathogens.
• Harmonizing existing data and developing pediatric-specific treatment guidelines are essential for managing IMIs in children.